European Commission approves nivolumab ipilimumab combo
The European Commission has approved nivolumab in combination with low-dose ipilimumab for first-line treatment of patients with intermediate and poor risk advanced... Read More
Kidney Cancer Awareness Week 4-8 February 2019
Click for more information our national awareness week and join our 'Plant a Seed For Research' campaign.
Living With Kidney Cancer days
Check the dates for our Living With Kidney Cancer days for 2019.
Natalie Newnes: Born to Run
Following a weight loss plan and giving birth to a lovely baby boy, Natalie Newnes started running marathons. Life could not have been... Read More
CHMP adopts a positive opinion of nivolumab + ipilimumab as 1st line treatment
Press release: Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo® (nivolumab) Plus Low-Dose Yervoy® (ipilimumab) as First-Line Treatment for Patients with... Read More
Kidney Cancer patients suffer high levels of stress
Distress Levels High Among Patients With Common Form of Kidney Cancer Many patients with renal cell carcinoma, the most common type of... Read More
Patient Survey Results Autumn 2018
Almost half of kidney cancer patients suffer initial misdiagnosis. Read the results from our Patient survey, Autumn 2018.
Phase 2 of study reports smaller tumors
AVEO Pharmaceuticals and EUSA Pharma said the Phase 2 portion of a study evaluating a treatment for renal cell carcinoma, the most common... Read More
Incidental CT scan turns Emma’s world on its head.
Emma Campbell went to her GP with an ache in her rib cage and a CT scan discovers a 4cm tumour on... Read More
Research into national kidney cancer screening programme
Mr Grant Stewart, talks about his research project, being part funded by Kidney Cancer UK, into a national screening programme for kidney cancer and his teams progress
Contrast-enhanced ultrasound aids diagnosis of kidney cancer
An enhanced ultrasound scan of the kidney is more accurate than computed tomography and magnetic resonance imaging in predicting cancer. A 10-year... Read More
cabozantinib, new first line treatment for kidney cancer
Once-daily tablet, CABOMETYX®▼(cabozantinib), approved by NICE as a first-line treatment for adult patients with Advanced Renal Cell Carcinoma (RCC) with intermediate or... Read More
Discovery of kidney cancer driver could lead to new treatment strategy
In a study published in the journal Science, researchers led by UNC Lineberger’s Qing Zhang, PhD, suggest that ZHX2 is a potential... Read More
Kidney Cancer Patient Survey 2018
Kidney Cancer UK and Kidney Cancer Scotland are proud to present our fifth annual kidney cancer survey which focuses exclusively on patients in the United Kingdom.
How ablation destroys cancer to prolong lives
A very interesting article in The Guardian (7th August 2018) relating to a much underused treatment for kidney cancer in the UK, Ablation.... Read More
A High Level of Circulating Vitamin D Protein Is Associated With a Decreased Risk of Kidney Cancer
Research focused on renal cell carcinoma appears to confirm the potential etiologic role of vitamin D binding protein in cancer. In what... Read More
Sugar Less September
Sugar Less September is a great opportunity to raise funds and to help yourself and your friends consume less sugar. Take on the challenge to reduce your sugar intake, become healthier and help kidney cancer patients.
Agent That Starves Tumor Cells May Improve Survival in Metastatic RCC
OncLive reports that a trial in the USA of novel glutaminase inhibitor CB-839, may provide a survival benefit in combination with cabozantinib (Cabometyx)... Read More
Be Clear on Cancer
Kidney Cancer UK are proud to be partnering with Public Health England on their 2018 Be Clear on Cancer campaign which calls for people to “tell their doctor” if they notice blood in their pee.
L’Étape Du Tour ride in Memory of father and grandmother
Kenneth Rogers, from Dunfermline, took on L’Étape Du Tour challenge after he lost his father to kidney cancer in 2017 and grandmother... Read More
Run in The London Marathon 2019
London Marathon 2019 have granted Kidney Cancer Scotland a ballot place for one lucky individual to run in the world famous race.... Read More
Kidney cancers caught stealing genes from other cell types in order to spread
The study, led by scientists from the MRC Cancer Unit at the University of Cambridge, suggests that this may also help to... Read More
Mindfulness – A Virtual Walk
We are delighted to be able to present to you in conjunction with Ten for Zen, our exclusive Martin Stepek ‘Mindfulness –... Read More
Cabozantinib Effective in Real-World Analysis for Relapsed Mrcc
Cabozantinib is a safe and effective treatment option for patients with relapsed renal cell carcinoma (RCC) in every clinical practice, according to... Read More